APA (7th ed.) Citation

Kupčová, V., Arold, G., Roepstorff, C., Højbjerre, M., Klim, S., & Haahr, H. (2014). Insulin Degludec: Pharmacokinetic Properties in Subjects with Hepatic Impairment. Clinical drug investigation, 34(2), 127-133. https://doi.org/10.1007/s40261-013-0154-1

Chicago Style (17th ed.) Citation

Kupčová, Viera, Gerhard Arold, Carsten Roepstorff, Malene Højbjerre, Søren Klim, and Hanne Haahr. "Insulin Degludec: Pharmacokinetic Properties in Subjects with Hepatic Impairment." Clinical Drug Investigation 34, no. 2 (2014): 127-133. https://doi.org/10.1007/s40261-013-0154-1.

MLA (9th ed.) Citation

Kupčová, Viera, et al. "Insulin Degludec: Pharmacokinetic Properties in Subjects with Hepatic Impairment." Clinical Drug Investigation, vol. 34, no. 2, 2014, pp. 127-133, https://doi.org/10.1007/s40261-013-0154-1.